Drug and device companies have just a month remaining to comment on a proposed rule that would require them to report all financial relationships with doctors.
As reported last year by MedPage Today and again Monday by the New York Times, the "Physician Payment Sunshine" provisions of the Affordable Care Act (ACA), require that drug, medical device, biologic, and medical equipment manufacturers that produce any products covered by Medicare or Medicaid or the Children's Health Insurance Program must report all payments made to doctors and hospitals.
The government will post the financial relationship information on a public website where patients and anyone else can check what ties to the medical industry a given doctor has.
The Centers for Medicare and Medicaid Services will accept comments on the proposal until Feb. 17, 2012, and will respond to them in a final rule to be published later this year.
Read the full story at:http://tinyurl.com/6motgc7
Source: MedPage Today
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Areas of Unmet Need Continue to Burden Patients With gMG
April 2nd 2025Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those treating and being treated for the chronic autoimmune neuromuscular disorder, to have a more nuanced understanding of experiences and difficulties.
Read More
AI in Health Care: Closing the Revenue Cycle Gap
April 1st 2025This commentary explores the current state, challenges, and potential of artificial intelligence (AI) in health care revenue cycle management, emphasizing collaboration, data standardization, and targeted implementation to enhance adoption.
Read More